Chemed Corporation (CHE)
CHE Price and Sentiment
CHE Latest news
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed (CHE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like CATY, BIO, CHE, MTLS and ABR.
Investors are optimistic about Chemed (CHE) on strong segmental growth and raised Roto-Rooter and earnings guidance for 2021.
This weekly article series provides a summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company's capital stock, payable on September 2, 2021, to shareholders of record as of August 16, 2021. This is a 2-cent, or 5.9%, increase over the 34-cent dividend paid in June 2021. The previous dividend increase was in August 2020, when the Board raised the quarterly dividend from 32-cents to 34-cents per share. This repre
Chemed Corporation (CHE) CEO Kevin McNamara on Q2 2021 Results - Earnings Call Transcript
Chemed (CHE) reports better-than-expected earnings and revenues with strong Roto-Rooter segment performance driving the top line in second-quarter 2021.